Analyst Price Target is $6.83
▲ +36.12% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Thorne HealthTech in the last 3 months. The average price target is $6.83, with a high forecast of $8.00 and a low forecast of $5.50. The average price target represents a 36.12% upside from the last price of $5.02.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in Thorne HealthTech.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.